Probiotic-assisted colon-specific delivery of diclofenac sodium from guar gum matrix tablets: In vitro evaluation

Asian Journal of Pharmaceutics

Volumn 4, Issue 4, 2010, Pages 173-178

  Ghosh, Prashant ^a   Gupta, Vipin ^b   Gondoliya, Bhavik ^b   Rathore, Mahendra ^b  

^a Naraina Industrial Area Phase II   (India)

^b B R NAHATA COLLEGE OF PHARMACY   (India)

Author keywords

Colon; diclofenac; guar gum; matrix tablet; probiotics

Indexed keywords

DICLOFENAC; GUAR GUM; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIFIDOBACTERIUM; CECUM; COLON; COLON FLORA; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; LACTOBACILLUS; MATRIX TABLET; NONHUMAN; RAT; TABLET FORMULATION;

EID: 79951977317     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.76734     Document Type: Article

References (25)

1. Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Del Rev 2005;57:247-65. (Pubitemid 39536101)
2. Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic drug delivery of 5-fluorouracil: An in vitro evaluation. Int J Pharm 2004;269:101-8. (Pubitemid 38032827)
3. Watts P, Illum L. Colonic drug delivery. Drug Dev Ind Pharm 1997;23:893-913. (Pubitemid 27406363)
4. Fatima LAA, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: Current perspectives. J Pharm Pharmaceut Sci 2006;3:327-38. (Pubitemid 46614339)
5. Libo Y, James SC, Joseph AF. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15.
6. Vandamme TF, Lenourry A, Charrueau C, Chaumeil JC. The use of polysaccharides to target drugs to the colon. Carbohydrate Polymers 2002;48:219-31. (Pubitemid 34141159)
7. Ishibashi T, Hatano H, Kobayashi M, Mizobe M, Yoshino H. In vivo drug release behaviour in dogs from a new colon-targeted delivery system. J Control Release 1999;57:45-53.
8. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 2003;6:33-66. (Pubitemid 37207241)
9. st ed. New Delhi: CBS Publishers and Distributors; 2001.
10. Wilson PJ, Basit AW. Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets. Int J of Pharm 2005;300:89-94. (Pubitemid 41112170)
11. Rubinstein A. Microbially controlled drug delivery to the colon. Bioph Drug Dispos 1990;11:465-75. (Pubitemid 20271436)
12. Sinha VR, Mittal BR, Kumria R. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm 2005;289:79-85.
13. Rubinstein A, Radai R, Ezra M, Pathak S, Rokem S. In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier. Pharm Res 1993;10:258-63.
14. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001;241:19-38. (Pubitemid 32706482)
15. Tuohy KM, Kolid S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructooligosaccharides - a human volunteer study. Br J Nutr 2001;86:341-8. (Pubitemid 32916191)
16. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997;18:833-41. (Pubitemid 28132475)
17. Muscat JE, Stellman SD, Wynder EL. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer (Phila) 1994;74:1847-54. (Pubitemid 24301843)
18. Stürmer T, Buring J, Lee I, Kurth T, Gaziano J, Glynn R. Colorectal Cancer After Start of Nonsteroidal Anti-Inflammatory Drug Use. Am J Med 2006;119:494-502. (Pubitemid 43795185)
19. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, et al. Antiproliferative effect of nonsteroidal anti-inflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 1994;3:433-8. (Pubitemid 24221454)
20. Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, et al. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res 1997;57:1625-9. (Pubitemid 27199647)
21. Falkowski M, Skogstad S, Shahzidi S, Smedsröd B, Sveinbjörnsson B. The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma. Anticancer Res 2003;23:2303-8. (Pubitemid 36897095)
22. Bjorkman R, Ullman A, Hedner J. Morphine-sparing effect of Diclofenac in cancer pain. Eur J Clin Pharmacol 1993;44:1-5. (Pubitemid 23030299)
23. Krishnaiah YS, Satyanarayana S, Rama Prasad YV, Narasimha SR. Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm 1998;171:137-46. (Pubitemid 29023106)
24. Tomlin J, Read NW, Edwards CA, Duerden BI. The degradation of guar gum by a faecal incubation system. Br J Nutr 1986;55:481-6. (Pubitemid 16086356)
25. Tomlin J, Read NW. The relation between bacterial degradation of viscous polysaccharides and stool output in human beings. Br J Nutr 1988;60:461-75.